Abivax ABVX
NASDAQ ABVX
$114.82 +0.79 (+0.69%)
As of: Sep 4, 2026 · 12:50 PM EDT

Abivax (ABVX) Shares Outstanding (Entity) (2021 - 2025)

Analysis

Abivax (ABVX) Shares Outstanding (Entity) (2021 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Entity.) (Qtr)
1 Vertex Pharmaceuticals 139.62 Bn 131.77 Bn 2.84 Bn 253.35 Mn
2 Regeneron Pharmaceuticals 85.73 Bn 77.73 Bn 3.93 Bn 102.80 Mn
3 Argenx Se 63.53 Bn 58.35 Bn 1.37 Bn -
4 Moderna 58.23 Bn 53.09 Bn 52.00 Mn 399.00 Mn
5 Revolution Medicines 44.05 Bn 44.05 Bn - 214.24 Mn
6 BeOne Medicines 40.03 Bn 34.93 Bn 1.53 Bn 113.02 Mn
7 Alnylam Pharmaceuticals 35.50 Bn 32.19 Bn 992.69 Mn 133.73 Mn
8 Royalty Pharma 28.52 Bn 27.68 Bn - 575.00 Mn
9 Insmed 27.46 Bn 26.30 Bn 358.27 Mn 218.28 Mn
10 Abivax 7.97 Bn 7.97 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 78.54 Mn
Dec 31, 2024 63.35 Mn
Dec 31, 2023 43.07 Mn
Dec 31, 2022 22.30 Mn
Dec 31, 2021 16.76 Mn